Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) testicular cancer team is composed of leaders in the field who are committed to providing you with the highest level of patient care. Our team of urologists; medical, surgical and radiation oncologists;
radiologists; and pathologists has decades of experience in diagnosing testicular cancer and employing the most innovative treatment options available. For testicular cancer alone, our cancer team cares for over 120 new patients per year, and has
more than 1,000 patients in follow-up since 2000 who are alive and doing well. The DF/BWCC testicular cancer team is at the forefront of testicular cancer research, and is one of the world's leading groups researching and publishing in testis cancer.
Patients coming to DF/BWCC benefit from state-of-the-art facilities, research and advanced care available only at an academic medical center. Studies show that men with testicular cancer have better outcomes at large-volume centers with specialized testicular
cancer experts. Having specialists from Urology, Surgical Oncology, Medical Oncology, Radiation Oncology and other specialties involved in your care ensures that all feasible approaches to treatment will be considered, and that you will receive the
combination of treatments that is best for you.
Meet the members of our testicular and genitourinary cancer treatment team.
New Patient Appointments